MedPath

Ksharaplota treatment in Dushtavrana

Phase 2/3
Not yet recruiting
Conditions
Unspecified multiple injuries,
Registration Number
CTRI/2020/08/027425
Lead Sponsor
Dr Anantkumar V Shekokar
Brief Summary

*Vrana*( wound and ulcer)& process of healingis the soul of *Shalyatantra Chikitsa* (Surgical treatment ) .*Dushta Vrana* means getting vitiated by*Dosha* & hence *Dushta Vrana* or infected wound is characterized bybad smell, abnormal color with profuse discharge, severe pain and longerhealing time*.*  The severity of infected wounds and their vastrange of etiologies,  The treatment  is cleaning & dressing the wound or it canbe more extensive.  It  may require surgical intervention to close the wound and stabilize the patient. *AcharyaSushruta* defines *Kshara* as the substance possessing *Ksharana*and *Kshanan* properties.

*Ksharaplota*formulation was selected and applied over the affected infected wound with thehelp of gauze piece. During the preparation of *Ksharaplota,* it is coatedwith *Snuhi kshira, Apamarga kshara & Haridra*. All these drugs are*Shodhana & Ropana*.It was observed that *Ksharaplota*has the properties as sustained release of drug, absorbs discharges, lesspainful & easily acceptable by the patient with excellent *Sodhana &Ropana* *Karma.* The clinical study has been done on 438 patients,selected randomly and divided in two groups. Group A 220 patients  i.e. trial group ,were treated with localapplication of Ksharaplota . The Group B 218 patients i.e. control group, weretreated with Gold standard . The clinical assessment was done on the basis ofclinical presentation of *Dushta Vrana*,(Infectedwound) before and after the treatment.

Asgrading used for assessment of parameters which were ordinal in nature,“Wilcoxon Signed Ranks test†was used for within the group assessment (i.e.before and after treatment of a group). For between the group assessment ofparameters, Mann Whitney – U test was applied. We had  tested hypothesis for each parameter andresult was interpreted accordingly. The level of significance was kept at 5%(P=0.05). And the result of the present study foundsignificant .

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
435
Inclusion Criteria

in the present study dushtavrana patients will be selected from the opd /Ipd of department of shalyatantra having sign of dushtavrana upto 6 cm length and breath 6 cm over extrimities.

Exclusion Criteria

Hb% lessthan 10 gm%.Malnourish patient (as per age ,height and weightproportion.Bleeding disorder.diabetes .AIDS,Tuberculosis,Hepatitis,Malaginancy, vericose ulcer.DVT.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Efficacy of Ksharaplota in Dushtavrana (infected wound)Efficacy of Ksharaplota in Dushtavrana (infected wound) in 4 years
Secondary Outcome Measures
NameTimeMethod
Chedana,Bhedana,Lekhana,shodhana,Ropana and wound healing properties of ksharaplota in Dushtavrana(Infected wound )4 years

Trial Locations

Locations (1)

Government Ayurved College

🇮🇳

Nanded, MAHARASHTRA, India

Government Ayurved College
🇮🇳Nanded, MAHARASHTRA, India
Dr Anantumar Shekokar
Principal investigator
dranantkumarshekokar@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.